Olympus
Olympus Corporation is a Japan-headquartered global medical technology company that manufactures endoscopes, endotherapy devices, and surgical energy instruments, serving hospitals, gastroenterologists, urologists, and surgeons across 19+ countries through direct enterprise sales and a 200+ service center network.
- Company typePublic
- Founded1919
- HeadquartersShinjuku, Japan
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Olympus does
Olympus Corporation, founded in 1919 and headquartered in Tokyo (Shinjuku), Japan, is a publicly listed global medical technology company (Tokyo Stock Exchange ticker 7733) that manufactures and sells medical endoscopes, endotherapy devices, and surgical energy and instrumentation products for minimally invasive diagnosis and treatment. Its core technology stack rests on proprietary optical imaging (Narrow Band Imaging, Auto Fluorescence Imaging, multilayer optical film coatings) integrated with a 4K surgical imaging platform (VISERA S), a comprehensive surgical energy portfolio (ESG-410 platform powering POWERSEAL advanced bipolar, THUNDERBEAT hybrid, and SONICBEAT ultrasonic devices), single-use endoscopy (RenaFlex ureteroscope), and — most recently — a cloud-based AI computer-aided detection system (CADDIE) developed by wholly-owned subsidiary Odin Vision for real-time colorectal polyp detection.
The company operates a direct, enterprise field sales model through regional subsidiaries (Olympus Corporation of the Americas in Center Valley, PA; Olympus Europa SE & Co. KG in Germany; Asia Pacific offices), serving hospitals, gastroenterologists, urologists, and general and specialty surgeons across 19+ countries. Revenue is generated primarily through capital equipment sales, recurring consumables tied to installed platforms, and a global service network of more than 200 repair centers. The company has 10,000+ employees globally (4,500+ in the Americas alone), multiple manufacturing plants in Japan (Aomori, Aizu, Shirakawa, Nagano/Ina, Hinode), and reports an adjusted operating margin expansion from 9.2% in FY2019 to 20.0% in FY2023 under its Transform Olympus corporate transformation program. Recent strategic activity includes FDA 510(k) clearances for the CADDIE AI system and RenaFlex ureteroscope in 2024, the acquisition of BioProtect Ltd. (urological/prostate cancer technologies, completed June 2026), and the divestiture of non-core businesses (cameras/audio to OM Digital Solutions in 2021; Life Science and Industrial Solutions to Evident in 2025).
Olympus firmographics
Firmographics- Name
- Olympus
- Legal name
- Olympus Corporation
- Website
- https://olympus-global.com
- Company type
- Public
- Founded year
- 1919
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Olympus Corporation is a Japan-headquartered global medical technology company that manufactures endoscopes, endotherapy devices, and surgical energy instruments, serving hospitals, gastroenterologists, urologists, and surgeons across 19+ countries through direct enterprise sales and a 200+ service center network.
- Ownership category
- akta.pro rank
Olympus industry classification
Industry- Product category
- Medical Endoscopy and Surgical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
- akta.pro secondary industries
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Reprocessing & Endoscope Infection Prevention (AERs, Drying/Storage, Leak Testing, Brushes) (HLAHANAJ)
Keywords
Where Olympus is headquartered
LocationHeadquarters
- HQ city
- Shinjuku
- HQ country
- Japan
- HQ region
- Asia
Offices14 records
Markets served
Olympus business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Medical Endoscopy Equipment Sales: Olympus generates primary revenue from selling medical endoscopes, endotherapy devices, and surgical energy products to hospitals and healthcare facilities globally. Products include reusable endoscopes, single-use devices (RenaFlex ureteroscope), and surgical energy instruments (POWERSEAL family).
- Surgical Energy Platform: ESG-410 Surgical Energy Platform powers the full range of Olympus Energy systems including monopolar, bipolar, ultrasonic, hybrid energy, and advanced bipolar devices. Revenue generated from capital equipment sales and compatible consumable devices.
- Global Service and Repair: Olympus maintains over 200 repair centers worldwide providing maintenance and repair services for endoscopes. Global Technical Service Guidelines ensure consistent quality worldwide. Repair service quality improvement activities have reduced return rates by half.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Olympus product offering
Product offeringCore offering
Olympus manufactures and sells medical endoscopes, endotherapy devices, and therapeutic energy (surgical) devices for minimally invasive diagnosis and treatment. Its portfolio spans gastrointestinal endoscopy systems, surgical energy instruments (POWERSEAL, THUNDERBEAT, SONICBEAT, ESG-410 platform), urology devices (RenaFlex single-use ureteroscope), and the AI-enabled Intelligent Endoscopy Ecosystem featuring the CADDIE cloud-based computer-aided detection system for real-time polyp detection during colonoscopy.
Product overview
Olympus is a global medical technology company focused on medical endoscopes, endotherapy devices, and therapeutic energy devices. The product portfolio centers on endoscopy solutions including the VISERA S 4K imaging platform and the Intelligent Endoscopy Ecosystem featuring cloud-based AI capabilities through the CADDIE computer-aided detection system. The surgical energy portfolio includes the POWERSEAL advanced bipolar sealing devices, THUNDERBEAT hybrid energy, and SONICBEAT ultrasonic dissectors, all powered by the ESG-410 Surgical Energy Platform. In urology, Olympus offers the RenaFlex single-use flexible ureteroscope, the CV-S1 Video System Center, and recently acquired BioProtect to expand urological technologies. The company also provides the OLYMPUS CONTINUUM platform for healthcare professional education and training.
Differentiator
Problem solved
Functional benefit
Brands
- VISERA S: New imaging platform launched in September 2024 for endoscopic diagnosis and therapy.
- POWERSEAL
- RenaFlex
- CADDIE
- THUNDERBEAT
- SONICBEAT
- OLYMPUS CONTINUUM
Products and services
- VISERA S Imaging Platform 4K imaging platform launched in September 2024 for enhanced visualization during endoscopic diagnosis and surgical procedures.
- CADDIE Computer-Aided Detection System Cloud-based AI Computer-Aided Detection (CADe) device for real-time polyp detection during colonoscopy procedures. FDA-cleared and CE-marked. Analyzes colonoscopy video in real-time and provides visual markers alerting endoscopists to suspected polyp locations.
- POWERSEAL Sealer/Divider Family Advanced bipolar surgical energy devices for vessel sealing, dissection, and grasping during laparoscopic or open surgery. Available in three jaw designs (Curved Jaw Double-action, Straight Jaw Double-action, Curved Jaw Single-action) and three shaft lengths. Consistent 7mm vessel sealing with greater than 99% probability of burst pressure above 360 mmHg.
- ESG-410 Surgical Energy Platform Surgical energy platform that powers the full range of Olympus Energy systems including monopolar, bipolar (HiQ, HICURA, PK, Everest), ultrasonic (SONICBEAT), hybrid energy (THUNDERBEAT), and advanced bipolar (POWERSEAL) devices.
- THUNDERBEAT Hybrid Energy Devices Hybrid energy surgical devices combining bipolar and ultrasonic energy for enhanced dissection and sealing capabilities during surgical procedures.
- SONICBEAT Ultrasonic Dissectors Ultrasonic surgical dissectors for tissue dissection and coagulation during laparoscopic procedures.
- RenaFlex Single-use Flexible Ureteroscope System FDA 510(k) cleared single-use flexible ureteroscope system for diagnostic and therapeutic procedures within the urinary tract, including kidney stone management. Features 9.5Fr outer diameter, 3.6Fr working channel, 270-degree up/down angulation, and advanced camera chip with 120-degree field of view.
- Aplio i800 EUS (Endoscopic Ultrasound) Endoscopic ultrasound (EUS) system for visualization and diagnosis. FDA-cleared with sales activities in Europe, Japan, and Oceania.
- 4K LCD Monitors 4K LCD monitors launched June 2026 for enhanced clarity in endoscopic diagnosis and therapy.
- 4K Camera Head for Urological Endoscopy 4K camera head designed for urological endoscopy procedures, launched in September 2024.
- OLYMPUS CONTINUUM Education Platform Healthcare professional education and training platform providing educational content for healthcare professionals on Olympus medical products and procedures.
- Intelligent Endoscopy Ecosystem Olympus AI-powered digital endoscopy ecosystem leveraging cloud connectivity and AI capabilities. Includes CADDIE device and supports doctors and hospitals in addressing cost pressures and staff shortages in the context of aging population.
Quantifiable outcome
- 7.3% absolute increase in adenoma detection rate using CADDIE AI-assisted colonoscopy
- +5 more outcomes
Companies that use Olympus
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
Olympus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Olympus partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Odin Medical Ltd. / Odin VisioncoreOdin Medical Ltd., trading as Odin Vision, is a Cloud AI endoscopy company and wholly-owned subsidiary of Olympus. Developed the CADDIE cloud-based AI computer-aided detection device for colonoscopy that received FDA 510(k) clearance. CEO Peter Mountney stated cloud technology enables hospitals to stay current with AI advances. The company represents Olympus's digital transformation strategy in endoscopy.
Scale indicators10 records
Recent moves8 records
Expansion highlights5 records
Olympus competitors and assessment
Company assessmentDirect peers
- CONMED: Specialty surgical and endoscopy device company directly competing with Olympus in advanced energy and GI/specialty endoscopy consumables and capital equipment.
- Fujifilm Healthcare: Fujifilm's Healthcare division sells endoscopy systems (including its own AI colonoscopy offerings) and competes directly with Olympus in GI endoscopy imaging and processing.
- Karl Storz: German family-owned medical device company and the other global leader in endoscopy systems and visualization, directly competing with Olympus in rigid and flexible endoscopes across surgical specialties.
- Pentax Medical (HOYA): HOYA's Pentax Medical division develops flexible endoscopy systems for GI and ENT, directly overlapping Olympus's GI and urology endoscopy portfolios.
Broad incumbents
- Boston Scientific: Broad medtech incumbent with significant presence in endoscopy (single-use scopes, hemostasis), urology, and surgical energy — overlapping with Olympus across multiple therapeutic areas.
- Intuitive Surgical: Dominant minimally invasive surgical robotics (da Vinci) incumbent that competes in the same OR budgets and laparoscopic procedure volumes as Olympus's surgical energy devices.
- Johnson & Johnson (Ethicon): J&J's Ethicon division is a leading surgical energy and advanced instrumentation competitor with overlapping laparoscopic energy devices like Harmonic and Enseal.
- Stryker: Large medtech incumbent competing in surgical visualization, energy, and OR integration; overlapping with Olympus's surgical energy and imaging-platform business units.
- Medtronic: Diversified medtech incumbent whose GI Genius AI polyp detection system and PillCam capsule endoscopy directly compete with Olympus's CADDIE and GI endoscopy franchise.
Emerging players
- Covis (Micro-Tech): Emerging player in endotherapy and single-use endoscopy accessories, competing with Olympus's biopsy and therapeutic device portfolio in gastroenterology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Olympus social profiles
Digital presenceOlympus compliance and trust
Trust signalCompliance7 records
Olympus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Olympus leadership team
Management profileNumber of profiles
Profiles5 records
Olympus subsidiaries and ownership
Company hierarchySubsidiaries2 records
Olympus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Olympus M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Olympus
What does Olympus do?
Olympus manufactures and sells medical endoscopes, endotherapy devices, and therapeutic energy (surgical) devices for minimally invasive diagnosis and treatment. Its portfolio spans gastrointestinal endoscopy systems, surgical energy instruments (POWERSEAL, THUNDERBEAT, SONICBEAT, ESG-410 platform), urology devices (RenaFlex single-use ureteroscope), and the AI-enabled Intelligent Endoscopy Ecosystem featuring the CADDIE cloud-based computer-aided detection system for real-time polyp detection during colonoscopy.
Is Olympus a public or private company?
Olympus is a public company. It is classified as public and is currently operating.
When was Olympus founded?
Olympus was founded in 1919. It employs 5,001 to 10,000 people.
Where is Olympus based?
Olympus is headquartered in Shinjuku, Japan, in the Asia region.
How does Olympus make money?
Three revenue lines are on record. Medical Endoscopy Equipment Sales are the primary driver. The others are surgical Energy Platform and global Service and Repair.
Who are Olympus's main competitors?
Direct peers on record are CONMED, Fujifilm Healthcare, Karl Storz and Pentax Medical (HOYA). Broad incumbents are Boston Scientific, Intuitive Surgical, Johnson & Johnson (Ethicon), Stryker and Medtronic. Covis (Micro-Tech) is listed as an emerging player.
Does Olympus have an API?
No public API is recorded for Olympus.
What industry is Olympus in?
Olympus's product category is Medical Endoscopy and Surgical Devices. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 339112 and its SIC code is 3841.